The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

Abstract Several anti-cancer therapies target the epidermal growth factor receptor (EGFR). Radionuclide imaging of EGFR expression in tumours may aid in selection of optimal cancer therapy. The 111In-labelled DOTA-conjugated ZEGFR:2377 Affibody molecule was successfully used for imaging of EGFR-expr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Javad Garousi, Ken G. Andersson, Johan H. Dam, Birgitte B. Olsen, Bogdan Mitran, Anna Orlova, Jos Buijs, Stefan Ståhl, John Löfblom, Helge Thisgaard, Vladimir Tolmachev
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/8a636f58f2cd44c59a45fa82c0cdd9f2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!